account_id none on file
legal_name Inhibikase Therapeutics, Inc.
ticker IKT
cik 1750149
domain inhibikase.com
linkedin_company_url https://www.linkedin.com/company/inhibikase-therapeutics/
entry_point_account_id none on file
name Inhibikase Therapeutics Inc.
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 4 executives 3 family 0
why_nownone on file
callsnone on file
filings
We previously leased office space in Lexington, Massachusetts under an operating lease that expired on September 30, 2025.
filing / Aug 11, 2026 / receipt
The Company recorded lease expense related to the Office Lease of $ 35,296 and $ 70,591 and other short-term payments of $ 4,731 and $ 9,863 for the three and six months June 30, 2025, respectively, in selling, general and administrative expenses.
filing / Aug 11, 2026 / receipt
We previously leased office space in Lexington, Massachusetts under an operating lease that expired on September 30, 2025.
filing / May 12, 2026 / receipt
The Company recorded lease expense related to the Office Lease of $ 35,296 and other short-term payments of $ 5,132 for the three months ended March 31, 2025, in selling, general and administrative expenses.
filing / May 12, 2026 / receipt
executives
| Chris Cabell | President | - | receipt |
| David McIntyre | Chief Financial Officer | - | receipt |
| Mark Iwicki | Chief Executive Officer | - | receipt |
familynone on file
upcoming
| 2026-11-13 | earnings call | scheduled | ir |
changes
| 2025-04-14 | Chief Financial Officer, appointed | sec_8k |
| 2025-04-14 | Chief Financial Officer, departed | sec_8k |
| 2025-02-24 | President, appointed | sec_8k |
| 2025-02-18 | President, appointed | sec_8k |
mcp_package_hint
slug inhibikase-therapeutics-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$